Equities

Tissue Regenix Group PLC

TRX:LSE

Tissue Regenix Group PLC

Health CarePharmaceuticals and Biotechnology
  • Price (GBX)62.00
  • Today's Change0.00 / 0.00%
  • Shares traded69.77k
  • 1 Year change10.71%
  • Beta1.9850
Data delayed at least 20 minutes, as of May 16 2024 16:35 BST.
More ▼

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments4.655.957.71
Total Receivables, Net3.514.643.60
Total Inventory10119.72
Prepaid expenses0.580.571.04
Other current assets, total------
Total current assets192222
Property, plant & equipment, net9.028.949.10
Goodwill, net121212
Intangibles, net3.553.473.48
Long term investments------
Note receivable - long term------
Other long term assets------
Total assets434646
LIABILITIES
Accounts payable1.213.442.57
Accrued expenses2.582.071.67
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.641.130.12
Other current liabilities, total0.31----
Total current liabilities4.746.644.36
Total long term debt8.758.477.83
Total debt9.409.617.95
Deferred income tax0.400.520.64
Minority interest(0.8)(0.85)(0.95)
Other liabilities, total------
Total liabilities131512
SHAREHOLDERS EQUITY
Common stock161616
Additional paid-in capital134134134
Retained earnings (accumulated deficit)(120)(119)(116)
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total------
Total equity303134
Total liabilities & shareholders' equity434646
Total common shares outstanding717070
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.